Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biologics Swing For The Fences: Payer Perspectives On Antibodies In Primary Care

12 Mar 2012

• By Michael Goodman

Related Content

Alder Obtains First Milestone Under BMS Deal, Advances Own Program In Cancer Supportive Care

21 Jun 2011

Bristol Pays $85 Million Upfront To Acquire Rheumatoid Arthritis Compound From Alder

10 Nov 2009

Amgen Expands Inflammation Pipeline With Avidia Purchase

29 Sep 2006

Medimmune Bets on Pain: Why The Large Molecule Specialist Thinks It Can Win

27 Jun 2011

Physicians Have Bigger Stake In Patients' Total Care Under Medicare ACOs

01 Apr 2011

Related Companies

Johnson & Johnson

Pfizer Inc.

Amgen, Inc.

MedImmune LLC

Priority Health Services

Alder Biopharmaceuticals, Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

GlycoFi Inc.

Adimab, LLC

Biogen, Inc.

Genentech, Inc.

Eli Lilly and Company

Amgen, Inc.

Novartis AG

Roche Holding AG

Additional Topics

Business Strategies Pricing Strategies Manufacturing BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.